Inovio Pharmaceuticals, Inc. (INO)
2.13
-0.04
(-1.84%)
USD |
NASDAQ |
Dec 11, 16:00
2.15
+0.02
(+0.94%)
After-Hours: 20:00
Inovio Pharmaceuticals Free Cash Flow: -89.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -89.31M |
| Perspective Therapeutics, Inc. | -106.85M |
| Arcturus Therapeutics Holdings, Inc. | -61.54M |
| Capricor Therapeutics, Inc. | -68.37M |
| Myomo, Inc. | -13.85M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.57M |
| Cash from Investing (Quarterly) | 8.867M |
| Cash from Financing (Quarterly) | 24.92M |
| Free Cash Flow Per Share (Quarterly) | -0.4148 |
| Free Cash Flow to Equity (Quarterly) | -21.00M |
| Free Cash Flow to Firm (Quarterly) | -21.64M |
| Free Cash Flow Yield | -103.2% |